To view this email as a web page, click here.
 
HOSPITAL REPORT
Pharmacists Credited for Decline in Hospital-Acquired Conditions
A new report highlights the important role you have in keeping patients safer than ever.
Read more
 
ADVERTISEMENT
 
FDA Issues Warning for Eluxadoline
Anti-IBS drug Viberzi (eluxadoline) increases risk of severe pancreatitis.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.